Virulence, immunogenicity and reactivation of bovine herpesvirus 1 mutants with a deletion in the gC, gG, gI, gE, or in both the gI and gE gene

Vaccine

Volumn 16, Issue 8, 1998, Pages 802-809

  Kaashoek, M J ^a   Rijsewijk, F A M ^a   Ruuls, R C ^a   Keil, G M ^b   Thiry, E ^c   Pastoret, P P ^c   Van Oirschot, J T ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b Fed Res Ctr for Virus Dis of A   (Germany)

^c Universite de Liege   (Belgium)

Author keywords

Bovine herpesvirus 1; Candidate vaccines; Deletion mutants; Immunogenicity; Reactivation; Virulence

Indexed keywords

GLYCOPROTEIN; HERPES SIMPLEX VACCINE; LIVE VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CATTLE; CONTROLLED STUDY; DELETION MUTANT; GENE CONSTRUCT; HERPES SIMPLEX VIRUS 1; IMMUNOGENICITY; NONHUMAN; PRIORITY JOURNAL; VIRULENCE; VIRUS INFECTION; VIRUS SHEDDING;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, VIRAL; CATTLE; CATTLE DISEASES; DEXAMETHASONE; GENES, VIRAL; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 1, BOVINE; RESPIRATORY TRACT INFECTIONS; SEQUENCE DELETION; SPECIFIC PATHOGEN-FREE ORGANISMS; VIRAL PROTEINS; VIRAL STRUCTURAL PROTEINS; VIRAL VACCINES; VIRULENCE; VIRUS ACTIVATION;

EID: 0032077307     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00269-7     Document Type: Article

References (22)

1. 1 Gibbs, E.P.J. and Rweyemamu, M.M. Bovine herpesviruses. Part 1. Veterinary Bulletin 1977, 47, 317-343.
2. 2 Roizman, B., Desrosiers, R.C., Fleckenstein, B., Lopez, C., Minson, A.C. and Studdert, M.J. The family Herpesviridae: an update. Archives of Virology 1992, 123, 425-449.
3. 3 Kimman, T.G., Pol, J.M.A. and De Wind, N. et al. Role of different genes in the virulence and pathogenesis of Aujeszky's disease virus. Veterinary Microbiology 1992, 33, 45-52.
4. 4 Kimman, T.G., De Wind, N. and Oei-Lie, N. et al. Contribution of single genes within the unique short region of Aujeszky's disease virus (suid herpesvirus type 1) to virulence, pathogenesis and immunogenicity. Journal of General Virology 1992, 73, 243-251.
5. 5 Balan, P., Davis-Poynter, N. and Bell, S. et al. An analysis of the in vitro and in vivo phenotypes of mutants of herpes simplex virus type 1 lacking glycoproteins gG, gE, gI or the putative gJ. Journal of General Virology 1994, 75, 1245-1258.
6. 6 Van Engelenburg, F.A.C., Kaashoek, M.J., Van Oirschot, J.T. and Rijsewijk, F.A.M. A glycoprotein E deletion mutant of bovine herpesvirus 1 infects the same limited number of tissues in calves as wild-type virus, but for a shorter period. Journal of General Virology 1995, 76, 2387-2392.
7. 7 Kaashoek, M.J., Van Engelenburg, F.A.C. and Moerman, A. et al. Virulence and immunogenicity in calves of thymidine kinase-and glycoprotein E-negative bovine herpesvirus 1 mutants. Veterinary Microbiology 1996, 48, 143-153.
8. 8 Miller, J.M. and Van Der Maaten, M.J. Reproductive tract lesions in heifers after intrauterine inoculation with infectious bovine rhinotracheitis virus. American Journal of Veterinary Research 1984, 45, 790-794.
9. 9 Rijsewijk, F., Kaashoek, M., Keil, G. et al. In vitro and in vivo phenotype and immunogenic properties of bovine herpes-virus 1 mutants with a deletion in the gC, gG, gI or gE gene. Proceedings of the 19th International Herpesvirus Workshop, Vancouver, 30 July-5 August 1994, p. 419.
10. 10 Taylor, G. Resistance to bovine respiratory syncytial virus (BRSV) induced in calves by a recombinant bovine herpes-virus 1 expressing the attachment glycoprotein of BRSV. Submitted.
11. 11 Kaashoek, M.J., Moerman, A. and Madic, J. et al. A conventionally attenuated glycoprotein E-negative strain of bovine herpesvirus type 1 is an efficacious and safe vaccine. Vaccine 1994, 12, 439-444.
12. 12 Spear, P.G. Entry of alphaherpesviruses into cells. Seminars in Virology 1993, 4, 167-180.
13. 13 Liang, X., Babiuk, L.A., Van Drunen Littel-Van Den Hurk, S., Fitzpatrick, D.R. and Zamb, T.J. Bovine herpesvirus 1 attachment to permissive cells is mediated by its major glycoproteins gI, gIII, and gIV. Journal of Virology 1991, 65, 1124-1132.
14. 14 Hung, S.L., Peng, C. and Kostavasili, I. The interaction of glycoprotein C of herpes simplex virus types 1 and 2 with the alternative complement pathway. Virology 1994, 203, 299-312.
15. 15 Liang, X., Babiuk, L.A. and Zamb, T.J. An in vivo study of a glycoprotein gIII-negative bovine herpesvirus 1 (BHV-1) mutant expressing β-galactosidase: evaluation of the role of gIII in virus infectivity and its use as a vector for mucosal immunization. Virology 1992, 189, 629-639.
16. s) of the bovine herpesvirus type 1 (ST strain). Virology 1994, 199, 409-421.
17. 17 McGeoch, D.J. Evolutionary relationships of virion glycoprotein genes in the S regions of alphaherpesvirus genomes. Journal of General Virology 1990, 71, 2361-2367.
18. 18 Card, J.P., Whealy, M.E., Robbins, A.K. and Enquist, L.W. Pseudorabies virus envelope glycoprotein gI influences both neurotropism and virulence during infection of the rat visual system. Journal of Virology 1992, 66, 3032-3041.
19. 19 Zsák, L., Zuckermann, F., Sugg, N. and Ben-Porat, T. Glycoprotein gI of pseudorabies virus promotes cell fusion and virus spread via direct cell-to-cell transmission. Journal of Virology 1987, 66, 2316-2325.
20. 20 Dingwell, K.S., Brunetti, C.R. and Hendricks, R.L. et al. Herpes simplex virus glycoproteins E and I facilitate cell-to-cell spread in vivo and across junctions of cultured cells. Journal of Virology 1994, 68, 834-845.
21. 21 Kaashoek, M.J., Rijsewijk, F.A.M. and Van Oirschot, J.T. Persistence of antibodies against bovine herpesvirus 1 and virus reactivation two to three years after infection. Veterinary Microbiology 1996, 53, 103-110.
22. 22 Kaashoek, M.J., Rijsewijk, F.A.M., Maris-Veldhuis, M.A. and Van Oirschot, J.T. Non essential glycoproteins gC, gG, gI and gE are expressed in all of 223 isolates of bovine herpesvirus 1. In: Marker vaccines against bovine herpesvirus 1 infection (Kaashoek, M.D.). PhD thesis, Utrecht University, 1995.